153 related articles for article (PubMed ID: 23000406)
1. Model for studying Clostridium botulinum neurotoxin using differentiated motor neuron-like NG108-15 cells.
Whitemarsh RC; Pier CL; Tepp WH; Pellett S; Johnson EA
Biochem Biophys Res Commun; 2012 Oct; 427(2):426-30. PubMed ID: 23000406
[TBL] [Abstract][Full Text] [Related]
2. Development of a Highly Sensitive Cell-Based Assay for Detecting Botulinum Neurotoxin Type A through Neural Culture Media Optimization.
Hong WS; Pezzi HM; Schuster AR; Berry SM; Sung KE; Beebe DJ
J Biomol Screen; 2016 Jan; 21(1):65-73. PubMed ID: 26420788
[TBL] [Abstract][Full Text] [Related]
3. A microscale neuron and Schwann cell coculture model for increasing detection sensitivity of botulinum neurotoxin type A.
Hong WS; Young EW; Tepp WH; Johnson EA; Beebe DJ
Toxicol Sci; 2013 Jul; 134(1):64-72. PubMed ID: 23564642
[TBL] [Abstract][Full Text] [Related]
4. Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines.
Yokosawa N; Kurokawa Y; Tsuzuki K; Syuto B; Fujii N; Kimura K; Oguma K
Infect Immun; 1989 Jan; 57(1):272-7. PubMed ID: 2535834
[TBL] [Abstract][Full Text] [Related]
5. Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1.
Schenke M; Prause HC; Bergforth W; Przykopanski A; Rummel A; Klawonn F; Seeger B
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437455
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.
Fredrick CM; Lin G; Johnson EA
Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455330
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.
Schenke M; Schjeide BM; Püschel GP; Seeger B
Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344847
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
[TBL] [Abstract][Full Text] [Related]
10. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
Kroken AR; Blum FC; Zuverink M; Barbieri JT
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
[TBL] [Abstract][Full Text] [Related]
12. In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5.
Pellett S; Tepp WH; Whitemarsh RC; Bradshaw M; Johnson EA
Toxicon; 2015 Dec; 107(Pt A):37-42. PubMed ID: 26130522
[TBL] [Abstract][Full Text] [Related]
13. Neuronal selectivity of botulinum neurotoxins.
Poulain B; Lemichez E; Popoff MR
Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
[TBL] [Abstract][Full Text] [Related]
14. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
[TBL] [Abstract][Full Text] [Related]
15. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
16. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
18. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
mSphere; 2016; 1(1):. PubMed ID: 27303710
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
Tepp WH; Lin G; Johnson EA
Appl Environ Microbiol; 2012 May; 78(9):3108-13. PubMed ID: 22367089
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I.
Yowler BC; Kensinger RD; Schengrund CL
J Biol Chem; 2002 Sep; 277(36):32815-9. PubMed ID: 12089155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
